KBC Group’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$721K Hold
30,934
﹤0.01% 749
2025
Q4
$1.37M Buy
30,934
+510
+2% +$28.6K ﹤0.01% 650
2025
Q3
$2.23M Hold
30,424
0.01% 577
2025
Q2
$1.87M Buy
30,424
+25,151
+477% +$1.4M 0.01% 597
2025
Q1
$306K Sell
5,273
-68,250
-93% -$4.31M ﹤0.01% 853
2024
Q4
$3.92M Buy
73,523
+70,227
+2,131% +$3.44M 0.01% 536
2024
Q3
$144K Buy
3,296
+614
+23% +$20.5K ﹤0.01% 1073
2024
Q2
$75K Buy
2,682
+301
+13% +$7.94K ﹤0.01% 1355
2024
Q1
$64K Hold
2,381
﹤0.01% 1394
2023
Q4
$67K Hold
2,381
﹤0.01% 1318
2023
Q3
$51K Buy
+2,381
New +$65K ﹤0.01% 1429

Other funds holding DOCS

KBC Group's DOCS Position: Q1 2026 in Review

KBC Group held its Doximity (DOCS) position steady in Q1 2026 at 30,934 shares worth $721K. The position accounts for ﹤0.01% of the portfolio, ranked #749.

KBC Group first reported a position in DOCS in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.92M in Q4 2024. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • KBC Group held 30,934 shares of Doximity worth $721K as of Q1 2026.
  • KBC Group left its Doximity share count unchanged in Q1 2026.
  • Doximity made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #749 holding.
  • KBC Group first reported a position in Doximity in Q3 2023 and has held it in 11 quarters since.
  • KBC Group's Doximity position peaked at $3.92M in Q4 2024.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.